Sotera Health

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sotera Health reports solid Q4 growth, cautious outlook for 2023

Sotera Health delivered growth in Q4 2022, closed a major litigation settlement, and outlined a cautious outlook for 2023. Strategic investments in EO enhancements and pharma growth signal long-term vision, while challenges in revenue and adjusted EPS are acknowledged. Overall, the company remains optimistic about future growth prospects.

Sotera Health reports Q1 revenue decline, eyes growth opportunities

Sotera Health faced revenue and EBITDA declines in Q1 2023 but remains optimistic about future growth prospects.
The company is addressing challenges in inflation, labor, and supply chains while focusing on operational improvements.
Opportunities for revenue growth exist through Nordion volumes, facility enhancements, and regulatory compliance efforts.
Overall, Sotera Health's performance reflects a mix of challenges, strengths, and opportunities for strategic advancement.

Sotera Health releases settlement funds, faces revenue declines in Q2

Sotera Health navigated challenges in Q2 2023 with declines in revenues and adjusted EBITDA but showcased strengths in strategic planning and operational efficiency.
The company's outlook remains positive, with opportunities for growth through capacity expansions and improved volumes in the second half of the year.
Addressing challenges in revenue performance and customer inventory levels will be crucial for sustaining growth and investor confidence.
Proactive measures and transparent communication underscore Sotera Health's commitment to navigating market uncertainties and driving long-term success.

Sotera Health reports revenue growth amidst challenges and opportunities

Sotera Health (SHC) delivered a mixed performance in Q3 2023 with revenue growth, margin improvement, and operational challenges.
The company maintains a strong liquidity position and is actively managing its financial metrics to drive long-term growth.
While facing challenges from external factors, Sotera Health (SHC) has opportunities to enhance efficiency and capitalize on growth prospects.

Sotera Health (SHC) posts robust Q4 results, eyes 2024 growth

Sotera Health (SHC) delivered strong financial performance in Q4 2023 and full year.
Operational achievements and resolved litigation bolstered the company's position.
Challenges include potential impact on revenue growth from Nordion contracts.
Optimistic outlook for 2024 with a focus on customer value and safety.

Sotera Health (SHC) reports robust Q1 performance and growth outlook

Sotera Health (SHC) delivered strong Q1 2024 results, reaffirming growth outlook and showcasing financial resilience.
Management's confidence in defense against lawsuits and compliance with regulations, alongside strategic investments, underpin the company's stability and growth potential.
With a focus on operational efficiency, capacity expansions, and investor engagement, Sotera Health (SHC) is poised for sustainable growth and value creation.

Sotera Health posts robust Q2 results, eyes efficiency and growth

Sotera Health delivered strong financial results in Q2 2024, supported by revenue growth and operational improvements across key segments.
Despite challenges such as FX headwinds and macroeconomic uncertainties, the company's solid liquidity position and debt refinancing strengthen its financial foundation.
Opportunities lie in optimizing cash flow, managing capital expenditures, and leveraging new board expertise for sustained growth and value creation.

Sotera Health reports robust Q3 growth, affirms 2024 outlook

Sotera Health's Q3 2024 performance reflects strong revenue and EBITDA growth across key business segments, underlining operational efficiency and market demand.
While facing challenges in regulatory compliance and market dynamics, the company's diverse strengths in critical sectors and upcoming Investor Day signal resilience and strategic focus.
By addressing challenges, leveraging opportunities, and maintaining growth momentum, Sotera Health aims to sustain its positive performance trajectory and investor appeal in the competitive landscape.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sotera has a stable, predictable and simple business model. Its services are essential and this is reflected in the fact that it has grown revenues every year since 2005.

Sotera Health: Buying A Premier Derisking Firm

News for Sotera Health Stock (SHC)